FR2244455B1 - - Google Patents

Info

Publication number
FR2244455B1
FR2244455B1 FR7432255A FR7432255A FR2244455B1 FR 2244455 B1 FR2244455 B1 FR 2244455B1 FR 7432255 A FR7432255 A FR 7432255A FR 7432255 A FR7432255 A FR 7432255A FR 2244455 B1 FR2244455 B1 FR 2244455B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7432255A
Other versions
FR2244455A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of FR2244455A1 publication Critical patent/FR2244455A1/fr
Application granted granted Critical
Publication of FR2244455B1 publication Critical patent/FR2244455B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7432255A 1973-09-26 1974-09-25 Expired FR2244455B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2348334A DE2348334C2 (de) 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs

Publications (2)

Publication Number Publication Date
FR2244455A1 FR2244455A1 (fr) 1975-04-18
FR2244455B1 true FR2244455B1 (fr) 1978-07-21

Family

ID=5893666

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7432255A Expired FR2244455B1 (fr) 1973-09-26 1974-09-25

Country Status (12)

Country Link
US (1) US3979520A (fr)
JP (1) JPS5632967B2 (fr)
AT (1) AT330954B (fr)
BE (1) BE820254A (fr)
CA (1) CA1029661A (fr)
DE (1) DE2348334C2 (fr)
FI (1) FI58068C (fr)
FR (1) FR2244455B1 (fr)
GB (1) GB1420907A (fr)
NL (1) NL174222C (fr)
SE (1) SE402210B (fr)
ZA (1) ZA745967B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3326167A1 (de) * 1983-07-20 1985-02-21 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung
CA1282405C (fr) * 1984-05-21 1991-04-02 Michael R. Violante Methode pour produire des particules dimensionnellement uniformes a partir des composes organiques insolubles dans l'eau
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
AU701042B2 (en) * 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
EE04294B1 (et) * 1997-08-26 2004-06-15 Hoechst Marion Roussel, Inc. Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
EP0974356B1 (fr) 1998-07-15 2003-09-24 Merck Sante Comprimés contenant une combinaison de glibenclamide et de metformine
US6586438B2 (en) * 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) * 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
WO2006109175A2 (fr) * 2005-04-11 2006-10-19 Aurobindo Pharma Limited Forme posologique solide pour un medicament antidiabetique
CN104098489A (zh) * 2014-07-10 2014-10-15 沈阳药科大学 一种微粉化格列本脲及其组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB694280A (en) * 1950-09-19 1953-07-15 Merck & Co Inc A stable, non-caking suspension of cortisone acetate in an isotonic aqueous vehicle and the process of preparing said composition
US3008873A (en) * 1957-02-07 1961-11-14 Merck & Co Inc Controlled particle size of 4, 4-dinitrocarbanilide
GB1030395A (en) * 1962-12-26 1966-05-25 Upjohn Co Hypoglycemic sulphonyl urea medicaments
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
DE2017495A1 (en) * 1970-04-11 1971-11-04 Merck Patent Gmbh, 6100 Darmstadt Sulphonamides embedded in galactomannans
JPS4932056B1 (fr) * 1970-12-22 1974-08-27

Also Published As

Publication number Publication date
BE820254A (fr) 1975-03-24
AU7365374A (en) 1976-04-01
JPS5632967B2 (fr) 1981-07-31
CA1029661A (fr) 1978-04-18
FI58068B (fi) 1980-08-29
FR2244455A1 (fr) 1975-04-18
AT330954B (de) 1976-07-26
SE402210B (sv) 1978-06-26
JPS5058216A (fr) 1975-05-21
ATA762374A (de) 1975-10-15
DE2348334C2 (de) 1982-11-11
FI58068C (fi) 1980-12-10
FI275574A (fr) 1975-03-27
NL7412393A (nl) 1975-04-01
NL174222C (nl) 1984-05-16
SE7412044L (fr) 1975-03-27
US3979520A (en) 1976-09-07
DE2348334A1 (de) 1975-03-27
ZA745967B (en) 1975-11-26
GB1420907A (en) 1976-01-14
NL174222B (nl) 1983-12-16

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU461342B2 (fr)
AU471461B2 (fr)
AR200256A1 (fr)
AU476873B1 (fr)
AR210729A1 (fr)
AU477824B2 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse